Related references
Note: Only part of the references are listed.Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
Yuesong Weng et al.
MICROBIOLOGY SPECTRUM (2023)
Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study
Jessica Howard-Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2022)
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial
Guoming Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)
Global colistin use: a review of the emergence of resistant Enterobacterales and the impact on their genetic basis
Ulrike Binsker et al.
FEMS MICROBIOLOGY REVIEWS (2022)
Colistin Heteroresistance Is Largely Undetected among Carbapenem-Resistant Enterobacterales in the United States
Victor Band et al.
MBIO (2021)
An optimized protocol for stepwise optimization of real-time RT-PCR analysis
Fangzhou Zhao et al.
HORTICULTURE RESEARCH (2021)
Tigecycline-non-susceptible hypervirulent Klebsiella pneumoniae strains in Taiwan
Yi-Hsiang Cheng et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis
Yawei Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae
Kimberly A. Walker et al.
MBIO (2020)
Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli
Thomas R. Aunins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study
Danxia Gu et al.
LANCET INFECTIOUS DISEASES (2018)
Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
Victor I. Band et al.
MBIO (2018)
Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads
Ryan R. Wick et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
Rong Zhang et al.
EBIOMEDICINE (2017)
Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013)
M. Cubero et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Clinical and Genomic Analysis of Liver Abscess-Causing Klebsiella pneumoniae Identifies New Liver Abscess-Associated Virulence Genes
Meiping Ye et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Johann D. D. Pitout et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Modeling Klebsiella pneumoniae Pathogenesis by Infection of the Wax Moth Galleria mellonella
Jose Luis Insua et al.
INFECTION AND IMMUNITY (2013)
Hypervirulent (hypermucoviscous) Klebsiella pneumoniae A new and dangerous breed
Alyssa S. Shon et al.
VIRULENCE (2013)
Lack of Heteroresistance among Staphylococcus aureus Isolates with Vancomycin MICs of 2 Micrograms per Milliliter by Automated Testing
Sarah W. Satola et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)